Medical Devices: Essential Components in Healthcare
The Pan American Health Organization recognizes medical devices as vital elements within health systems, offering a myriad of advantages, including improved diagnosis and treatment, continuous monitoring of chronic illnesses, enhanced experiences for both patients and clinicians, effective management of medical devices, and the generation of innovative ideas through data analysis.
To better understand the market dynamics, it has been segmented into three primary categories: device type, application, and end-user. The device type is further divided into various segments, encompassing drug delivery systems, diagnostic devices, invasive devices, respiratory therapeutic devices, electronic medical devices, and others. Each of these serves distinct purposes in the realm of healthcare. Applications for medical devices are diversified, ranging from cardiovascular diseases, diagnostic imaging, orthopedics, oncology, ophthalmology, general surgery, respiratory support, dental care, Ear, Nose, and Throat (ENT) treatments, neurology, nephrology & urology, and more. The end-user segment is also multifaceted, including hospitals & clinics, ambulatory surgical centers, home care settings, and other healthcare facilities.
A noticeable trend influencing the market is the increasing shift toward home care settings, leading to a growing demand for portable medical devices. This shift is driven by the desire for more accessible and personalized healthcare options. The convenience and flexibility offered by portable devices align with the changing preferences in healthcare delivery. This transition is reshaping the landscape of medical device usage, with an emphasis on making healthcare more patient-centric.
The growth of the global medical devices market is further propelled by ongoing technological advancements. As technology continues to evolve, medical devices become more sophisticated, enabling accurate diagnoses, efficient treatments, and improved patient outcomes. This technological progress also supports the development of innovative solutions, fostering the integration of data-driven insights into healthcare practices.
One significant factor contributing to the expansion of the medical devices market is the rising prevalence of chronic diseases. Conditions such as cardiovascular diseases, diabetes, and respiratory disorders are becoming increasingly common, driving the demand for advanced medical devices that aid in monitoring, managing, and treating these chronic conditions. The ability of medical devices to provide continuous health monitoring and timely interventions aligns with the global healthcare focus on preventive and personalized medicine.
Report Attribute/Metric | Details |
---|---|
Market Size Value In 2023 | USD 534.46 Billion |
Growth Rate | Â 5.4% |
Medical Devices Market size was valued at USD 534.45 Billion in 2023 and is projected to grow from USD 571.80 Billion in 2024 to USD 984.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.03% during the forecast period (2024 - 2032). Shift towards Homecare Settings is Boosting the Demand for Portable Devices, Increasing Technological Advancement, and Rising prevalence of chronic diseases boosts the demand for medical devices are driving the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
In Europe, the Middle East and Africa (EMEA), in April 2024, Johnson & Johnson (J&J) finally launched two new devices: The Ethizia haemostatic sealing patch and the Cereglide aspiration catheter.
Shift towards Homecare Settings is Boosting the Demand for Portable Devices boosting the market growth.
The rising prevalence of chronic conditions and treatment of patients suffering from these diseases is exerting huge pressure on the healthcare systems of many countries. The overall costs of treating a patient in a hospital inpatient setting are significantly higher, and longer hospital stays are associated with a higher economic burden. For instance, according to the Centers for Disease Control and Prevention (CDC), the economic burden of treatment of diabetic foot ulcers in the U.S. was approximately USD 13 billion to USD 15 billion each year. Therefore, with the efforts taken by healthcare agencies to shift patients towards home care settings, also market players are actively investing in research and development of advanced and easy-to-use medical equipment such as specialized beds, person-lifting and transferring equipment, and toileting aids for the treatment of chronic disorders. Their efforts have resulted in the introduction of portable and wearable devices that can be easily used by patients at home without the need for professional assistance.
Drug delivery devices, are pharmaceutical formulations or devices that help in achieving targeted delivery or Controlled Release (CR) of therapeutic agents in the body. The drug delivery systems are segmented into metered dose inhaler devices, infusion systems, and other Companies such as Bayer AG (Germany), Johnson & Johnson (US), and Baxter International, Inc. (US) among others are the key players offering drug delivery systems.
Diagnostic devices are tools used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. The diagnostic devices are segmented into laboratory based diagnostic devices, wearable diagnostic devices, and others. Laboratory based diagnostic devices are further segmented into X-ray, Computed Tomography (CT), and Positron Emission Tomography (PET). Wearable diagnostic devices are segmented into vital signs monitors, fetal and obstetric monitoring devices, and others.
Any medical devices that are inserted into the body is considered an invasive device. The invasive devices are segmented into implants and stimulation devices, defibrillators, pacemakers, and others. In addition, a rise in the number of minimally invasive surgery devices due to its higher acceptance rate over traditional surgeries, increasing prevalence of chronic diseases such as cardiovascular diseases, and technological advancement in the invasive devices are anticipated to drive the growth of the invasive devices segment.
Respiratory therapeutic devices are mainly utilized to improve pulmonary functions by cleaning the airway, increasing lung oxygen intake capacity, and facilitating mucus evacuation from the bronchi. The respiratory therapeutic devices are segmented into ventilators, oxygen concentrators, resuscitators, and others. These respiratory therapeutic devices are also used to help in the treatment of a variety of chronic illnesses associated with respiratory problems such as Chronic Obstructive Pulmonary Disease (COPD), bronchitis, sleep disorders, asthma, and other chronic illnesses.
Electronic medical devices include pacemakers, defibrillators, drug-releasing pumps, hearing aids, and diagnostic equipment for measuring, monitoring, and recording body functions such as heartbeat and brain waves. The electronic medical devices are segmented into monitoring devices, massage chairs, heating blankets, electronical hospital beds, and others. Monitoring devices are further segmented into sphygmomanometer, pulse oximeter, digital thermometers, brain wave meter, electrocardiogram meter, body fat meter, bone density meter, physiological monitoring system, and others that include blood gas & electrolyte analyzers.
Other medical devices include endoscopy devices, ophthalmology devices, and wound management medical devices among others. Endoscopy is a minimally invasive medical treatment that identifies, prevents, and treats visceral organ disorders such as Inflammatory Bowel Disease (IBD). These devices are implanted in the body either through natural cavities (such as the anus and mouth) or through incisions, particularly in arthroscopy.
Rising prevalence of cardiovascular diseases such as heart failure, stroke, cardiomyopathy, and others are expected to drive the growth. According to the World Health Organization (WHO), large population people died suffering from cardiovascular diseases in 2019 globally
The diagnostic imaging is the technique of creating visual illustrations of the inner body for clinical examination and medical interpolation, along with the visual representation of the function of certain organs or tissues. It includes ultrasound, X-Ray, Positron Emission Tomography (PET), Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) scanners are used for spot diagnosis, monitoring disease progression, treatment planning, and evaluation of the efficacy of treatment for several chronic diseases such as cancer and others.
The rising prevalence of orthopedics diseases such as osteoarthritis, rheumatoid arthritis, and degenerative disc disease among others, and the growing aging population across the globe are expected to drive the market growth. For instance, as per the National Institutes of Health (US), the prevalence of degenerative disc disease is typically proportional to age, with large number of old age people having degenerative disc disease, rising to 80% among those aged 80 years or over.
Rising prevalence of cancer which is directly influence demand for medical devices such as Computed Tomography (CT), Positron Emission Tomography (PET), and Magnetic Resonance Imaging (MRI) among others are anticipated to drive the market growth. For instance, according to World Health Organization (WHO) figures, cancer is the primary or second leading cause of death as well as large number of populations suffering from cancer disease.
Ophthalmic diseases consist of illness related to the eyes that includes glaucoma, cataract, and other vision-related issues. In addition, the rising prevalence of ophthalmic disease also raises the demand. For instance,, according to the American Academy of Ophthalmology (AAO), in the US alone, in the year 2019, a major population aging population and above suffer from vision impairment, with about a million suffering from blindness.
Increasing cases of anal & distal rectal cancer, esophageal cancer, gall bladder disorders, hernia repair, and other chronic diseases all over the globe are some of the key contributing factors to the growth of the segment. The various devices such as electrical cautery, dermatome, laser scalpel, and other medical & surgical equipment are used to perform various general surgeries.
Respiratory system are used to mechanically support the impaired gas exchange function of the patients. A major share of the population is experiencing respiratory issues. As per the report presented by ResMed at the American Thoracic Society (ATS) 2018 International Conference, a large number of world population suffered from Obstructive Sleep Apnea (OSA) resulting in abnormal breathing patterns. Such illness requires respiratory support for normalizing breathing patterns
Similarly, as per the European Respiratory Journal in 2018, the major population suffering from OSA.
Dental cone-beam computed tomography, dental lasers, dental implants, and others are used for diagnosis and treatment planning of dental problems and maintaining dental health. The rising prevalence of oral health disorders and growing demand for dental care facilities for efficient dental surgical procedures are the major factors propelling the growth of the market.
ENT devices such as endoscopes, hearing screening devices, and hearing implants among others are used to treat various ENT disorders such as cholesteatoma, sinusitis, and others. The rising geriatric population, increasing prevalence of ENT-related disorders, and increasing penetration of minimally invasive ENT procedures are among the key trends stimulating market growth.
Neurological disorders include Alzheimer’s disease, vascular dementia, Parkinson’s disease, multiple sclerosis, neuropathies, epilepsy, and other disorders. The rising prevalence of these diseases is increasing the demand for neurodiagnostic, neuro-interventional, and neurostimulation devices among others for the diagnosis and treatment of neurological disorders. According to the Alzheimer's Association (US), Alzheimer’s dementia may affect 13.8 million Americans aged 65 and above.
The increasing patient population suffering from diabetes, blood pressure, chronic kidney disease, fluid & electrolyte disorders, prostate cancer, and other nephrology & urologic diseases drives the market growth. For instance, according to the U.S. Department of Health & Human Services, in 2021, a major population in the US suffered from chronic kidney disease. As there is a rising prevalence of diabetes and high blood pressure among adults, there is a high risk of developing Chronic Kidney Disease (CKD) and urological disorder.
The other applications involve the use of dermatology, gynecological diseases, and Infectious diseases among others. Dermatology diagnostic & treatment devices such as imaging devices, electrosurgery devices, and others help in diagnosing and treatment of skin disorders such as psoriasis, eczema, acne, rosacea, ichthyosis, vitiligo, etc.
Figure 2: MEDICAL DEVICES MARKET, BY APPLICATION, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Rising prevalence of cardiovascular diseases such as heart failure, stroke, cardiomyopathy, have augmented the utilization of the medical devices in hospitals & clinics across diverse geographies. According to the World Health Organization (WHO), in 2019 a large population across the globe died suffering from cardiovascular diseases.
Ambulatory surgical centers are outpatient surgery centers that provide diagnostic and preventive services. The ambulatory surgical centers perform same-day surgeries such as cataract surgery, gall bladder removal, abdominal hernia repair, skin therapy, and others.
The homecare settings segment is growing tremendously due to the availability of better treatment for the patient and external factors such as the COVID-19 pandemic, making it difficult for patients to visit hospitals & clinics. Some electronic medical devices enable people to manage their own homecare settings more conveniently and independently such as pulse oximeters, digital thermometers, massage chairs, heating blankets, and others.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American accounted for the largest market share in 2022 driven by technological advancements and a growing emphasis on healthcare innovation. The region is witnessing substantial growth in various segments of medical devices, including diagnostic equipment, surgical instruments, and therapeutic devices. Factors driving this expansion include a robust healthcare infrastructure, increasing healthcare expenditure, and a rising aging population. Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MEDICAL DEVICES MARKET BY REGION 2022 & 2032
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe market is expected to account for the second-largest market share due to the favorable health policies and trend towards integrating health services, including counseling. Further, the German market was attributed to holding the largest market share, and France market is expected to fastest-growing market in the European region.
The Asia-Pacific healthcare counseling market is expected to grow at the fastest rate from 2023 to 2030. This is due to the rising spending in healthcare, quickly evolving healthcare infrastructure, growing awareness regarding Medical Devices, and growing population in the region. Moreover, China’s market is expected to hold the largest market share, and India market is expected fastest-growing market in the Asia-Pacific region.
The Rest of the World includes the Middle East, Africa, and Latin America. The main factors influencing the growth of Medical Devices in the Middle East and Africa. MEA region has experienced significant growth propelled by increasing focus on healthcare infrastructure development, rising healthcare awareness, and a growing population, MEA countries are witnessing a surge in demand for Africa medical devices.
Medical Devices Key Market Players & Competitive Insights
The characterized by the presence of many global, regional, players. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the globe with diverse Type portfolios. Companies such as Abbott (US), Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Johnson & Johnson Services Inc. (US), Medtronic (Ireland)) dominate the due to Type differentiation, financial stability, strategic services, and diversified regional presence. The players are focused on investing in extensive research and development as well. Furthermore, they adopt strategic growth initiatives, such as expansion, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
Key Companies in the Medical Devices Market include
Medical Devices Industry Developments
Abbott became one of the companies that received approval from the US Food and Drug Administration to treat abnormal or slow heart rhythms using their dual chamber leadless pacemaker AVEIR dual chamber (DR). Such was done in July 2023.
Osiris Therapeutics is a manufacturer of regenerative therapy tools, among other products used to heal wounds; a value proposition that Smith & Nephew also holds on this issue of improving medical solutions for such complications was supported after they announced the acquisition of Osiris therapeutics by Smith & Nephew Company in February 2023 which makes it a global medical technology company.
GE Healthcare's head-only MRI scanner received FDA clearance on November 14, 2024. This system is designed to reduce scan times and enhance patient comfort, particularly for individuals with claustrophobia.
In July 2024, GE Healthcare acquired the clinical AI business from Intelligent Ultrasound for $51 million. This move aims to integrate advanced AI capabilities into diagnostic imaging.
In 2024, Stryker continued to innovate in robotic-assisted surgery and orthopedic devices, with a focus on enhancing patient outcomes through technological advancements. Specific product or partnership details for the year are pending confirmation from direct sources.
In November 2024 highlighted the potential of Boston Scientific’s Watchman device for patients undergoing cardiac ablation for atrial fibrillation. It offers an alternative to long-term blood thinners.
Boston Scientific completed a $3.7 billion acquisition of Axonics on November 15, 2024. This strategic purchase aims to enhance their portfolio in neuromodulation and incontinence management.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)